The writing is on the wall at Mural Oncology. Responding to clinical data, the biotech is laying off 90% of its employees and ...

Despite setbacks for projects trying to harness the power of the cytokine interleukin-2 (IL-2) as a cancer therapy, there are still plenty of players on the field – and Roche has just joined ...

Mural Oncology is halting development of its lead IL-2 therapy and enacting major layoffs after its second trial failure this ...

PT101 is an engineered IL-2 mutein fused to a protein backbone ... that are trying to flip that on its head and try to use the cytokine to protect organs from autoimmune reactions.

As a global leader in recombinant technology, Sino Biological has developed a wide range of GMP-grade cytokines, including IL-2, IL-12, IL-15, IL-21, EGF, FGF2, Activin A, OSM, and others, which ...

Two new papers uncover IL-17 biology and add to growing evidence that cytokines can influence behavior during illness.